3WIG | Transferase Transferase Inhibitor | date | Sep 12, 2013 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Human Mek1 Kinase In Complex With Ch5126766 And Mgamp-Pnp | ||||||||||||||
authors | C.M.Lukacs, C.Janson, V.Schuck | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Dual Specificity Mitogen-Activated Protein Kinase Chain: A Synonym: Map Kinase Kinase 1, Mapkk 1, Mkk1, Erk Activator Mapkerk Kinase 1, Mek 1; Ec: 2.7.12.2 Engineered: Yes Other_details: Unp Residues 62-270, 303-393 |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Map2k1, Mek1, Prkmk1 Expression_system: Escherichia Coli Expression_system_taxid: 562 Expression_system_vector_type: Plasmid | ||||||||||||||
symmetry | Space Group: P 31 2 1 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.70 Å | ||||||||||||
ligand | ANP, CHU, CL, MG, PG4 | enzyme | Transferase E.C.2.7.12.2 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Disruption of CRAF-Mediated MEK Activation Is Required for Effective MEK Inhibition in KRAS Mutant Tumors., Lito P, Saborowski A, Yue J, Solomon M, Joseph E, Gadal S, Saborowski M, Kastenhuber E, Fellmann C, Ohara K, Morikami K, Miura T, Lukacs C, Ishii N, Lowe S, Rosen N, Cancer Cell. 2014 May 12;25(5):697-710. doi: 10.1016/j.ccr.2014.03.011. Epub 2014, Apr 17. PMID:24746704 |
Data retrieval |
View 3WIG in 3D |
Visual 3D analysis of 3WIG |
Structure-derived information |
Sequence-derived information |
Other resources with information on 3WIG |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |